DeVinney Erick Wayne (CIK 1595972) reported 19 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-18). Recent activity: Buy AXGN (6,363 shares), Sell AXGN (2,870 shares), Buy AXGN (11,575 shares), Sell AXGN (5,221 shares), Buy AXGN (33,780 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-18 | Axogen, Inc. (AXGN) | Chief Innovation Officer | Buy | 6,363 | $0 |
| 2026-03-18 | Axogen, Inc. (AXGN) | Chief Innovation Officer | Sell | 2,870 | $94,251 |
| 2026-03-18 | Axogen, Inc. (AXGN) | Chief Innovation Officer | Buy | 11,575 | $0 |
| 2026-03-18 | Axogen, Inc. (AXGN) | Chief Innovation Officer | Sell | 5,221 | $171,458 |
| 2026-03-02 | Axogen, Inc. (AXGN) | Chief Innovation Officer | Buy | 33,780 | $0 |
| 2026-03-02 | Axogen, Inc. (AXGN) | Chief Innovation Officer | Sell | 10,702 | $341,394 |
| 2026-03-02 | Axogen, Inc. (AXGN) | Chief Innovation Officer | Sell | 11,276 | $345,609 |
| 2025-12-10 | Axogen, Inc. (AXGN) | Chief Innovation Officer | Sell | 19,517 | $609,126 |
| 2025-12-05 | Axogen, Inc. (AXGN) | Chief Innovation Officer | Buy | 40,000 | $0 |
| 2025-09-16 | Axogen, Inc. (AXGN) | Chief Innovation Officer | Buy | 2,500 | $0 |
| 2025-09-16 | Axogen, Inc. (AXGN) | Chief Innovation Officer | Sell | 1,137 | $18,522 |
| 2025-03-19 | Axogen, Inc. (AXGN) | Chief Innovation Officer | Buy | 2,950 | $0 |
| 2025-03-19 | Axogen, Inc. (AXGN) | Chief Innovation Officer | Buy | 6,362 | $0 |
| 2025-03-19 | Axogen, Inc. (AXGN) | Chief Innovation Officer | Buy | 23,150 | $0 |
| 2025-03-19 | Axogen, Inc. (AXGN) | Chief Innovation Officer | Sell | 15,111 | $264,442 |
| 2025-03-04 | Axogen, Inc. (AXGN) | Chief Innovation Officer | Buy | 24,799 | $0 |
| 2025-03-04 | Axogen, Inc. (AXGN) | Chief Innovation Officer | Sell | 8,296 | $152,232 |
| 2025-02-26 | Axogen, Inc. (AXGN) | Chief Innovation Officer | Buy | 2,500 | $0 |
| 2025-02-26 | Axogen, Inc. (AXGN) | Chief Innovation Officer | Sell | 972 | $16,038 |
Source: SEC Form 4 filings · as of 2026-03-18